BR0016951A - Derivado de fenilpiperazinil, composto, composição farmacêutica, uso do mesmo, método de tratamento - Google Patents

Derivado de fenilpiperazinil, composto, composição farmacêutica, uso do mesmo, método de tratamento

Info

Publication number
BR0016951A
BR0016951A BR0016951-0A BR0016951A BR0016951A BR 0016951 A BR0016951 A BR 0016951A BR 0016951 A BR0016951 A BR 0016951A BR 0016951 A BR0016951 A BR 0016951A
Authority
BR
Brazil
Prior art keywords
treatment
compound
pharmaceutical composition
phenylpiperazinyl
derivative
Prior art date
Application number
BR0016951-0A
Other languages
English (en)
Inventor
Thomas Ruhland
Benny Bang-Andersen
Kim Andersen
Mario Rottlander
Jan Kehler
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of BR0016951A publication Critical patent/BR0016951A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

"DERIVADOS DE FENILPIPERAZINILA, COMPOSTO, COMPOSIçãO FARMACêUTICA, USO DO MESMO, MéTODO DE TRATAMENTO". A presente invenção refere-se a uma classe inovadora de derivados de fenilpiperazinil tendo a fórmula (i) onde X, Z, Y, U, V, Alqui, W, R^ 1^, R^ 2^, R^ 11^, R^ 12^, n. m e a linha pontilhada são como definidas na descrição. Os compostos da invenção são ligandos receptores de Dopamina D4 e são desta forma úteis para o tratamento de determinados distúrbios psiquiátricos e neurológicos, incluindo psicoses.
BR0016951-0A 1999-12-30 2000-12-20 Derivado de fenilpiperazinil, composto, composição farmacêutica, uso do mesmo, método de tratamento BR0016951A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901886 1999-12-30
PCT/DK2000/000720 WO2001049677A1 (en) 1999-12-30 2000-12-20 Phenylpiperazinyl derivatives

Publications (1)

Publication Number Publication Date
BR0016951A true BR0016951A (pt) 2003-02-25

Family

ID=8108810

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0016951-0A BR0016951A (pt) 1999-12-30 2000-12-20 Derivado de fenilpiperazinil, composto, composição farmacêutica, uso do mesmo, método de tratamento

Country Status (24)

Country Link
US (1) US20030083336A1 (pt)
EP (1) EP1246815B1 (pt)
JP (1) JP2003519223A (pt)
KR (1) KR20020067589A (pt)
CN (1) CN1437596A (pt)
AR (1) AR029217A1 (pt)
AT (1) ATE261958T1 (pt)
AU (1) AU2152001A (pt)
BG (1) BG106961A (pt)
BR (1) BR0016951A (pt)
CA (1) CA2395867A1 (pt)
DE (1) DE60009154D1 (pt)
EA (1) EA200200731A1 (pt)
HU (1) HUP0203645A3 (pt)
IL (1) IL150337A0 (pt)
IS (1) IS6431A (pt)
MX (1) MXPA02006499A (pt)
NO (1) NO20023149L (pt)
NZ (1) NZ519692A (pt)
PL (1) PL355540A1 (pt)
SK (1) SK11062002A3 (pt)
TR (1) TR200201684T2 (pt)
WO (1) WO2001049677A1 (pt)
ZA (1) ZA200204970B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040002488A1 (en) * 2002-05-29 2004-01-01 Cowart Marlon D. Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
NZ540612A (en) * 2003-01-14 2008-02-29 Arena Pharm Inc 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
EP1927594A1 (en) * 2003-01-14 2008-06-04 Arena Pharmaceuticals, Inc. 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
MXPA06007172A (es) 2003-12-23 2006-08-23 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-bencilamina como ssri.
AR052308A1 (es) 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
EP1836192A2 (en) * 2005-01-03 2007-09-26 Universita' Degli Studi di Siena Aryl piperazine derivatives for the treatment of neuropsychiatric disorders
US7629473B2 (en) 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
KR100868353B1 (ko) * 2007-03-08 2008-11-12 한국화학연구원 도파민 ｄ4 수용체 길항제인 신규 피페라지닐프로필피라졸유도체, 이의 제조방법 및 이를 포함하는 약학적 조성물
EP2619198A1 (en) 2010-09-22 2013-07-31 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2015090235A1 (en) 2013-12-20 2015-06-25 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use thereof
WO2015169180A1 (en) * 2014-05-04 2015-11-12 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods and use thereof
CN105085491B (zh) * 2014-05-05 2019-06-25 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
GB201416352D0 (en) 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives
GB201416351D0 (en) 2014-09-16 2014-10-29 Shire Internat Gmbh Heterocyclic derivatives
CN105732591B (zh) * 2014-12-31 2019-10-25 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途
EP4445956A2 (en) 2015-01-06 2024-10-16 Arena Pharmaceuticals, Inc. Compound for use in treating conditions related to the s1p1 receptor
WO2016209809A1 (en) 2015-06-22 2016-12-29 Arena Pharmaceuticals, Inc. Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid(compound1) for use in sipi receptor-associated disorders
WO2017012579A1 (zh) * 2015-07-23 2017-01-26 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
WO2017025058A1 (zh) * 2015-08-13 2017-02-16 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
WO2018151873A1 (en) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
GB9305623D0 (en) * 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents
GB9306578D0 (en) * 1993-03-30 1993-05-26 Merck Sharp & Dohme Therapeutic agents
WO1994024105A1 (en) * 1993-04-15 1994-10-27 Merck Sharp & Dohme Limited Indole derivatives as dopamine d4 antagonists
AU694212B2 (en) * 1994-04-28 1998-07-16 Merck Sharp & Dohme Limited Benzofuran derivatives as d4 receptor antagonists
JP3004727B2 (ja) * 1994-08-05 2000-01-31 ファイザー・インコーポレーテッド ドパミン作動性活性を有するベンゾイミダゾール誘導体
USH2007H1 (en) * 1996-01-19 2001-12-04 Fmc Corporation Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines

Also Published As

Publication number Publication date
CA2395867A1 (en) 2001-07-12
DE60009154D1 (de) 2004-04-22
HUP0203645A3 (en) 2004-01-28
TR200201684T2 (tr) 2002-10-21
CN1437596A (zh) 2003-08-20
IL150337A0 (en) 2002-12-01
HUP0203645A2 (hu) 2003-02-28
ATE261958T1 (de) 2004-04-15
KR20020067589A (ko) 2002-08-22
EP1246815B1 (en) 2004-03-17
PL355540A1 (en) 2004-05-04
NO20023149D0 (no) 2002-06-28
WO2001049677A1 (en) 2001-07-12
SK11062002A3 (sk) 2002-12-03
NZ519692A (en) 2004-05-28
US20030083336A1 (en) 2003-05-01
NO20023149L (no) 2002-06-28
AU2152001A (en) 2001-07-16
EA200200731A1 (ru) 2002-12-26
MXPA02006499A (es) 2002-11-29
BG106961A (en) 2003-04-30
IS6431A (is) 2002-06-19
JP2003519223A (ja) 2003-06-17
ZA200204970B (en) 2004-01-26
EP1246815A1 (en) 2002-10-09
AR029217A1 (es) 2003-06-18

Similar Documents

Publication Publication Date Title
BR0016951A (pt) Derivado de fenilpiperazinil, composto, composição farmacêutica, uso do mesmo, método de tratamento
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
EA200100203A1 (ru) Производные 4,4-биарилпиперидина с активностью в отношении опиоидных рецепторов
LU92113I2 (fr) Perampanel et ses dérivés pharmaceutiquement acceptables (FYCOMPA)
BRPI0414514A (pt) uso de um composto, composto, e, composições farmacêuticas
NZ516599A (en) 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
MXPA02001764A (es) Compuestos heteropoliciclicos y su uso como antagonistas de receptor de glutamato metabotropico.
ATE226574T1 (de) 4,6-diarylpyrimidin-derivate und deren salze
ATE377602T1 (de) Morphinanderivate und ihre medizinische anwendung
BR9712507A (pt) Derivados de aminotiazol, seu processo de preparo e as composições famacêuticas que os comtêm.
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
TR200200125T2 (tr) Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar.
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
BG105710A (en) 5ht1 antagonists for antidepressant therapy
ATE210642T1 (de) 2-substituierte vitamin-d3-derivate
FI935799A (fi) Aryylisubstituoituja heterosyklisiä yhdisteitä
ES2162856T3 (es) Derivados de ergolina serotoninergicos.
DK0604355T3 (da) Arylsubstituerede heterocykliske forbindelser
BG105923A (en) Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
EA199900765A1 (ru) Новые производные эритромицина, способ их получения и их применение в качестве лекарственных средств
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
FR2565487B1 (fr) Compositions therapeutiques a base de nouveaux derives de l'aminomethyl-6 furo-(3,4-c)-pyridine
EP1227098A4 (en) TRIAZOLPURINE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THEM AND MEANS THAT SHOW AFFINITY TO THE ADENOSINE A3 RECEPTOR
BR9915898A (pt) Compostos, composição farmacêutica, e, utilização de um composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1929 DE 26/12/2007.